T1	Participants 47 94	women experiencing vaginal and Caesarean births
T2	Participants 319 337	Montreal hospitals
T3	Participants 359 462	999 trial participants for whom follow-up data were available, 135 delivered by Caesarean section (CS),
T4	Participants 467 496	864 had a vaginal birth (VB).